Effect of atorvastatin on vascular function and blood lipid in coronary heart disease patients with percutaneous coronary intervention

ZHOU Yongfeng; DANG Weili

doi:10.7619/jcmp.202014027

Journal of Clinical Medicine in Practice > 2020 > 24(14): 100-102. > DOI: 10.7619/jcmp.202014027

ZHOU Yongfeng, DANG Weili. Effect of atorvastatin on vascular function and blood lipid in coronary heart disease patients with percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 100-102. DOI: 10.7619/jcmp.202014027

Citation:

PDF (472 KB)

Effect of atorvastatin on vascular function and blood lipid in coronary heart disease patients with percutaneous coronary intervention

ZHOU Yongfeng¹,
DANG Weili^2, ,

1. The First Department of Cardiovascular Diseases, Yulin City Xingyuan Hospital, Yulin, Shaanxi, 719000;
2. Department of Pharmacy, Baoji City Stomatological Hospital, Baoji, Shaanxi, 721001

More Information

Received Date: March 21, 2020

Graphical Abstract

Abstract

Abstract

Objective To explore the effect of atorvastatin on vascular endothelial function and blood lipid indexes in coronary heart disease patients with percutaneous coronary intervention(PCI). Methods A total of 90 patients with coronary heart disease after PCI were randomly divided into treatment group and control group, with 45 cases in each group. The control group was treated with conventional drugs for coronary heart disease, and the treatment group was treated with atorvastatin on the basis of the control group. Blood lipid indexes(including high-density lipoprotein, low-density lipoprotein, total cholesterol, triglyceride), vascular endothelial function indexes(vascular endothelial growth factor, nitric oxide)and incidence of adverse cardiovascular events were compared between the two groups before and after treatment. Results The levels of total cholesterol, triglyceride and low density lipoprotein in the treatment group were significantly lower than those in the control group(P<0.05), and the level of high-density lipoprotein was significantly higher than that of the control group(P<0.05). After treatment, the levels of vascular endothelial growth factor and nitric oxide in the treatment group were significantly higher than those in the control group(P<0.05). After treatment, the incidence of adverse cardiovascular events in the treatment group was 6.67%, which was significantly lower than 26.67% in the control group(P<0.05). Conclusion Atorvastatin is safe and effective in the treatment of patients with coronary heart disease after PCI, which can regulate levels of blood lipid indexes and reduce the incidence of adverse cardiovascular events.
- atorvastatin,
- coronary heart disease,
- percutaneous coronary intervention,
- vascular endothelial growth factor,
- total cholesterol

FullText(HTML)

References (17)

References

张月超. 硫酸氢氯吡格雷片联合阿托伐他汀钙对冠心病PCI术后心绞痛患者血清血脂水平、sCD40L及sICAM-1水平的影响[J]. 标记免疫分析与临床, 2019, 26(7): 1200-1203

, 1227.

赵培, 陶金, 袁晓晨, 等. 冠心病患者PCI术后长期高剂量阿托伐他汀治疗的疗效及安全性[J]. 临床心血管病杂志, 2017, 33(3): 226-230.

符丽珍, 肖孟生. 阿托伐他汀联合丹参川芎嗪对冠心病心肌梗死患者介入治疗后血清胱抑素C、髓过氧化物酶的影响[J]. 现代中西医结合杂志, 2016, 25(19): 2128-2130.

雷肖蠢, 邱军杰. 不同负荷剂量阿托伐他汀钙对高龄冠心病患者经皮冠状动脉介入术后预后影响的对比研究[J]. 实用心脑肺血管病杂志, 2017, 25(3): 58-61

, 72.

杨丽霞, 周玉杰, 王志坚, 等. 老年冠心病患者行经皮冠状动脉介入术术前强化他汀治疗的有效性和安全性研究[J]. 心肺血管病杂志, 2016, 35(3): 170-174.

周云, 渠乐, 朱小莉, 等. 阿托伐他汀强化治疗对冠脉介入冠心病患者的保护作用研究[J]. 现代生物医学进展, 2016, 16(27): 5317-5320.

熊小栓, 曾繁芳, 陈娟, 等. 阿托伐他汀序贯疗法对择期PCI治疗患者降脂和抗炎作用的疗效[J]. 心血管康复医学杂志, 2018, 27(4): 440-444.

景强强, 姚龙. 冠心病患者PCI围术期双倍剂量阿托伐他汀干预的效果及安全性分析简[J]. 中南医学科学杂志, 2016, 44(5): P. 544-547.

雷斌. 曲美他嗪联合阿托伐他汀对冠心病心绞痛的治疗效果分析[J]. 中国急救医学, 2018, 38(z1): 68-70.

贾和. 阿托伐他汀钙片对冠心病患者经皮冠状动脉介入术后预后的影响[J]. 实用心脑肺血管病杂志, 2017, 25(S1): 42-44.

许承志, 朱坤, 王其海, 等. 术前强化他汀治疗对冠心病病人PCI术后心肌标志物及炎性指标的影响[J]. 蚌埠医学院学报, 2017, 42(5): 641-644.

曹爱华, 李刚, 宋文静. 不同剂量阿托伐他汀对冠心病介入患者调脂、抗炎和安全性研究[J]. 河北医药, 2017, 39(22): 3470-3472.

张远生, 史丽. 瑞舒伐他汀与阿托伐他汀对冠心病伴高脂血症患者的临床研究[J]. 中国临床药理学杂志, 2019, 35(4): 315-318.

张可英, 李秀昌. 阿托伐他汀与氟伐他汀对冠心病患者心率变异性的影响[J]. 山东医药, 2016, 56(33): 44-46.

冯小智. 阿托伐他汀对冠心病患者血脂及内皮脂酶的影响[J]. 实用心脑肺血管病杂志, 2016, 24(4): 110-112.

吕园园, 刘力, 王志权. 丹参川芎嗪注射液联合阿托伐他汀对冠心病并糖尿病患者血脂、血流变、内皮功能和心功能的影响[J]. 湖北中医药大学学报, 2017, 19(3): 17-20.

阿荣, 张迎军, 汉迪, 等. 阿托伐他汀对冠心病患者疗效及血清SAA、apoA-Ⅰ、sP-Selectin水平的影响[J]. 检验医学与临床, 2016, 13(23): 3317-3319

, 3322.

[1]	ZHANG Yang, DIAO Haiqing, Li Mengyue, TIAN Ting, LIU Xiaoguang, MA Qiang, LU Guangyu, YU Hailong, LI Yuping. Influencing factors of aspiration in neurological critically ill patients: a Meta-analysis[J]. Journal of Clinical Medicine in Practice, 2025, 29(1): 118-124. DOI: 10.7619/jcmp.20242193
[2]	QIN Qi, Alimujiang·YUSUFU, LIU Yuzhe, YIN Can, CUI Sha, RAN Jian. Efficacy of femoral neck system and cannulated screw in treatment of femoral neck fracture: a meta-analysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(2): 63-72. DOI: 10.7619/jcmp.20231674
[3]	Alimujiang·YUSUFU, Azigu·YUSUFU, Abudula·ABULAITI, RAN Jian. Meta-analysis of the efficacy and safety of non-steroidal anti-inflammatory drugs in bone healing period[J]. Journal of Clinical Medicine in Practice, 2023, 27(21): 17-24. DOI: 10.7619/jcmp.20232256
[4]	LIU Ping, JIANG Xuelian, MA Jing, QIN Siyi, LIN Mujun. Meta-analysis of the intervention effect of olfactory disorders in patients with pituitary tumor after operation[J]. Journal of Clinical Medicine in Practice, 2023, 27(13): 32-36. DOI: 10.7619/jcmp.20230799
[5]	JIANG Haoyue, YU Shujun, TANG Yibo, SHEN Zhenru, LIU Zhejun, TANG Tian, WANG Shuaiqiang, TONG Kejin, LIU Zhenquan. Meta-analysis of efficacy of Shengjing Capsules (Tablets) in the treatment of oligoasthenospermia[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 46-54. DOI: 10.7619/jcmp.20222610
[6]	ZHU Yuting, CHEN Ying, WANG Xinxin, TIAN Miao, KONG Xiang, WANG Yan. Effect of high-intensity exercise during pregnancy on maternal and neonatal outcomes: A Meta-analysis[J]. Journal of Clinical Medicine in Practice, 2021, 25(6): 97-105. DOI: 10.7619/jcmp.20210051
[7]	ZHAO Yan, LI Li, DONG Xianhui, WANG Juyang. Effect of ketogenic diet in the treatment of patients with type 2 diabetes: a Meta-analysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 87-97. DOI: 10.7619/jcmp.202018025
[8]	QU Tao, ZHANG Honggang, CUI Chengxu, YANG Lin. Correlation between CYP2A6 polymorphisms and clinical outcome of S-1-based chemotherapy in patients with advanced cancer: A meta-analysis[J]. Journal of Clinical Medicine in Practice, 2015, (3): 15-19. DOI: 10.7619/jcmp.201503004
[9]	ZHOU Qingyun, WEI Zhongqing, CHEN Xinmei. Meta-analysis of evidence-based nursing of patients with transurethral resection of prostate[J]. Journal of Clinical Medicine in Practice, 2014, (22): 71-74. DOI: 10.7619/jcmp.201422022
[10]	WANG Zihui, HAN Feifei, LIU Lihong. A meta-analysis of relationship between acid-suppressive drugs ingested by pregnant women and their descendent asthma[J]. Journal of Clinical Medicine in Practice, 2014, (19): 88-90. DOI: 10.7619/jcmp.201419026

Cited By

Cited by

Periodical cited type(9)

1.	胡武彩，周桂生. 尿八联检验联合定量尿培养在尿路感染中的诊断效能. 系统医学. 2024(03): 61-64 .
2.	邱玉琳. 全血C反应蛋白和白细胞及尿常规联合检测对尿路感染的诊断价值. 医疗装备. 2024(15): 74-76 .
3.	武颖，龚正，刘航，王美燕，燕慧. 2019—2020年北京市丰台中西医结合医院的尿细菌培养情况及药敏分析. 中国当代医药. 2023(11): 157-160 .
4.	崔玉荣. 干化学法与尿沉渣法在尿常规检验中的应用价值. 实用检验医师杂志. 2023(03): 258-261 .
5.	杨海东，周文博，罗景，段南均. 上尿路结石感染的病原学特征及即刻引流效果分析. 实用临床医药杂志. 2022(05): 71-74 . 本站查看
6.	杨超，刘健，申忠华，崔海军，张慧民，郝俊秀，裴琼. 唐山市工人医院2018年-2021年泌尿系结石感染患者的细菌谱变迁及药敏特点分析. 中国现代医学杂志. 2022(15): 79-84 .
7.	周旭瑜. Mejer-7001尿沉渣分析仪与细菌培养检查诊断尿路感染的一致性分析. 基层医学论坛. 2021(14): 2026-2027 .
8.	宋培培，张琴，许健，王秦，刘成桂. 某三甲医院儿童和成年女性尿培养病原菌分布和耐药性分析. 现代生物医学进展. 2021(12): 2344-2349 .
9.	郑萍萍，张丽华. 改良尿标本留取方式对中段尿培养结果的影响. 名医. 2021(22): 80-81 .

Other cited types(1)

Get Citation

PDF

XML

Article views (429) PDF downloads (11) Cited by(10)

Turn off MathJax

Article Contents

Abstract

References

Effect of atorvastatin on vascular function and blood lipid in coronary heart disease patients with percutaneous coronary intervention

Abstract

References

Related Articles

Cited by

Periodical cited type(9)

Other cited types(1)

Catalog

Effect of atorvastatin on vascular function and blood lipid in coronary heart disease patients with percutaneous coronary intervention

Abstract

References

Related Articles

Cited by

Periodical cited type(9)

Other cited types(1)

Catalog

Export File

Citation

Format

Content